Skip to main content
Average ER Wait Times

Heart Hospital of Austin

-- mins

St. David's Children's Hospital

-- mins

St. David's Georgetown Hospital

-- mins

St. David's Medical Center

-- mins

St. David's North Austin Medical Center

-- mins

St. David's Round Rock Medical Center

-- mins

St. David's South Austin Medical Center

-- mins

Austin’s First Blood and Marrow Transplant Specialist to Practice at St. David’s South Austin Medical Center

St. David's HealthCare January 21, 2015

AUSTIN, TX — Aravind Ramakrishnan, M.D., has joined the Texas Transplant Institute to lead the Blood and Marrow Transplant (BMT) Program at the Sarah Cannon Blood Cancer Center at St. David’s South Austin Medical Center. In this role, Dr. Ramakrishnan will perform BMT procedures at the center, provide physician leadership for the unit and build collaborations across Central Texas. The Sarah Cannon Blood Cancer Center at St. David’s South Austin Medical Center is part of St. David’s CancerCare—a partnership between St. David’s HealthCare and Sarah Cannon designed to provide patients with a more coordinated and comprehensive approach to cancer services in Central Texas.

The Sarah Cannon Blood Cancer Center at St. David’s South Austin Medical Center is uniquely structured to address the needs of Central Texas by bringing together recognized physician leadership in oncology care from Texas Oncology and Texas Transplant Institute®.

“The addition of Dr. Ramakrishan will allow us to expand our capabilities and enable us to provide blood cancer and stem cell transplant patients with world-class care right here in Austin” Laurence K. Tokaz, M.D., an oncologist at Texas Oncology and medical director of the Sarah Cannon Blood Cancer Center at St. David’s South Austin Medical Center, said.

Prior to joining Texas Transplant Institute, Dr. Ramakrishnan served in various clinical research roles at the Fred Hutchinson Cancer Research Center in Seattle, Washington, ultimately serving as an assistant member of the clinical research division. Additionally, he served as an attending physician at the University of Washington Medical Center, where he provided inpatient BMT services. He also served as an attending physician at the Seattle Cancer Care Alliance, providing outpatient allogeneic and autologous BMT services, as well as at treating patients with myelodysplastic syndromes and myeloproliferative diseases.

Dr. Ramakrishnan earned his Bachelor of Science degree in biological sciences from the George H. Cook Campus at Rutgers University in New Brunswick, New Jersey, and he received his medical degree from the Robert Wood Johnson Medical School, formerly an academic unit of the University of Medicine and Dentistry of New Jersey. He completed his internship and residency in internal medicine at Baylor College of Medicine and completed his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center.

Dr. Ramakrishnan is certified by the American Board of Medical Oncology and the American Board of Internal Medicine. In addition to serving as an assistant professor at the University of Washington, he has also earned numerous medical awards, including the Baylor College of Medicine’s Best Clinic Physician Award and the University of Medicine and Dentistry of New Jersey’s Research Award. Dr. Ramakrishnan has also been awarded funding for a number of projects, including research to develop myelodysplastic patient-specific induced pluripotent stem cells (iPSC) that will serve as a resource to model the disease process. His findings have been published in numerous publications.

Dr. Ramakrishnan assumed his new role at the Sarah Cannon Blood Cancer Center at St. David’s South Austin Medical Center in September.

Sarah Cannon is the global cancer enterprise of HCA (Hospital Corporation of America) which facilitates a full range of physician-led, patient-centric integrated cancer care services in local markets and offers the highest level of quality standards, infrastructure, training and research for patients with cancer treated within affiliated partner facilities.

A recognized leader in the treatment of blood cancers, the Texas Transplant Institute’s blood and marrow stem cell transplant program was established at Methodist Hospital in San Antonio in 1993. The program has performed nearly 2,000 bone marrow transplants since its inception, and it is ranked as one of the largest in the nation.

St. David’s South Austin Medical Center

St. David’s South Austin Medical Center, located at 901 West Ben White Boulevard, is part of St. David’s HealthCare, one of the largest health systems in Texas, which was recognized with a Malcolm Baldrige National Quality Award—the nation’s highest presidential honor for performance excellence through innovation, improvement and visionary leadership—in 2014 and recognized as one of the top 15 health systems in the U.S. by Thomson Reuters in 2012. St. David’s South Austin Medical Center is an acute care facility with 304 beds, offering a range of complex specialties and sub-specialties, including a comprehensive and nationally recognized cardiac program, full-service maternity and newborn care with Level I and II nurseries, a thriving 24-hour emergency department, and two full-service emergency centers in the communities of Bee Cave and Bastrop. The medical center recently completed a comprehensive, $72-million renovation and expansion project. For more information, please visit StDavids.com.

News Related Content